RenovoRx (RNXT) Common Equity (2020 - 2026)
RenovoRx (RNXT) reported Common Equity of $8.98 million for Q2 2026, down 15.6% from $10.64 million a year earlier and down 20.3% from the prior quarter.
Powered by 
Analysis
RenovoRx (RNXT) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, RenovoRx posted Common Equity of $5.42 million, up 21.1% from FY2024.
- By year, Common Equity came in at $4.48 million in FY2024 (+49.3%), $3 million in FY2023 (-51.3%), $6.16 million in FY2022 (-59.8%) and $15.35 million in FY2021.
- Five-year quarterly Common Equity spans a low of $6,000 in Q3 2023 and a high of $17.55 million in Q3 2021.
- Year over year, Common Equity gained in five of the last seven quarters, with growth averaging 102.0%.
- The high point for year-over-year Common Equity in five years was Q2 2024 (growth of 680.5%); the low point was Q3 2023 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.27 million (Q1 2026), $5.42 million (Q4 2025) and $8.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.42 Bn |
| 10 | RenovoRx | 70.84 Mn | 70.84 Mn | 766,000.00 | 8.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.98 Mn |
| Mar 31, 2026 | 11.27 Mn |
| Dec 31, 2025 | 5.42 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 10.64 Mn |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 4.48 Mn |
| Sep 30, 2024 | 7.07 Mn |
| Jun 30, 2024 | 9.27 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 3.26 Mn |
| Dec 31, 2022 | 6.16 Mn |
| Sep 30, 2022 | 8.15 Mn |
| Jun 30, 2022 | 10.12 Mn |
| Mar 31, 2022 | 12.54 Mn |
| Dec 31, 2021 | 15.35 Mn |
| Sep 30, 2021 | 17.55 Mn |
API Access
RenovoRx Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RNXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RNXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RNXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();